![]() CMG Pharmaceutical CMG Pharmaceutical is a company that specializes in the oral thin film (OTF) technology. | ![]() Balmes Transplantation Balmes Transplantation is a pharmaceutical company focused on kidney ischemia-reperfusion injury (IRI), including acute kidney injury and kidney transplantation. | ![]() ThermoGenesis ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics. | |||
Founding Date | Founding Date 1978 | Founding Date 2001 | Founding Date 2016 | Founding Date 2015 | Founding Date 1986 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Seongnam-si, KR HQ | Locations Brisbane, US HQ | Locations Marseille, FR HQ | Locations Rancho Cordova, US HQ Wuxi Shi, CN |
Employees | Employees 4,9082% increase | Employees 273 | Employees 1011% increase | Employees 3 | Employees 5338% decrease |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ₩105.2b (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $9.4m (FY, 2023) |
Cost of goods | Cost of goods N/A | Cost of goods ₩43.4b (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $7.5m (FY, 2023) |
Gross profit | Gross profit N/A | Gross profit ₩61.8b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $1.9m (FY, 2023) |
Net income | Net income N/A | Net income (₩10.1b) (FY, 2025) | Net income N/A | Net income N/A | Net income ($18.9m) (FY, 2023) |
Funding | |||||
Total funding raised | Total funding raised $ 255.2m | Total funding raised N/A | Total funding raised $ 8.3m | Total funding raised N/A | Total funding raised $ 15m |

CMG Pharmaceutical is a company that specializes in the oral thin film (OTF) technology.
View company
Spiral Therapeutics is a hearing loss biopharmaceutical company.
View company
Balmes Transplantation is a pharmaceutical company focused on kidney ischemia-reperfusion injury (IRI), including acute kidney injury and kidney transplantation.
View company
ThermoGenesis Holdings (formerly known as Cesca Therapeutics) is a regenerative medicine company that develops, commercializes and markets a range of automated technologies for cell-based therapeutics.
View company